AI Article Synopsis
- Endovascular treatment for carotid artery stenosis offers a less invasive alternative to open surgery, with advancements in stent materials and protection devices lowering the risk of neurological complications.
- Nitinol double-layer micromesh stents have shown promise in reducing the chances of cerebral embolization during and after surgery.
- The paper discusses a case of a 66-year-old woman who experienced partial stent thrombosis three months after receiving carotid artery stenting for asymptomatic stenosis.
Article Abstract
Endovascular treatment of carotid artery stenosis is a valuable alternative to open surgery, and the evolution of stent materials and cerebral protection devices significantly decreased postoperative neurological complications. Among these, the introduction of nitinol double-layer micromesh stent seems to guarantee a reduced perioperative and postoperative cerebral embolization. Long-term results are however still not available to make a global evaluation of these stents. We present the case of a 66-year-old female patient treated for asymptomatic carotid stenosis complicated by a symptomatic partial stent thrombosis occurred three months after carotid artery stenting.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.avsg.2018.10.030 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Not only acute respiratory failure: COVID-19 and the post-intubation/tracheostomy upper airways lesions.
Front Surg
March 2023
Unit of Thoracic Surgery, Department of Precision and Regenerative Medicine and Ionian Area (DiMePre-J), University of Bari "Aldo Moro", Bari, Italy.
Background: An increasing number of patients have been subjected to prolonged invasive mechanical ventilation due to COVID-19 infection, leading to a significant number of post-intubation/tracheostomy (PI/T) upper airways lesions. The purpose of this study is to report our early experience in endoscopic and/or surgical management of PI/T upper airways injuries of patients surviving COVID-19 critical illness.
Materials And Methods: We prospectively collected data from patients referred to our Thoracic Surgery Unit from March 2020 to February 2022.
Nitinol double-layer stent versus closed single-layer stent: a systematic review.
Rev Assoc Med Bras (1992)
December 2022
Universidade de São Paulo, Faculdade de Medicina - São Paulo (SP), Brazil.
The Pennsylvania Postmarket Multicenter Experience With Flow Redirection Endoluminal Device.
Neurosurgery
August 2022
Department of Neurosurgery, Hospital of the University of Pennsylvania, Penn Medicine, Philadelphia, Pennsylvania, USA.
Background: The flow redirection endoluminal device (FRED) is a novel self-expanding double-layer nitinol braided flow diverter that recently received FDA approval. However, early postmarket studies from the United States are lacking.
Objective: To report our short-term multicenter experience.
Carotid artery stenting with Roadsaver stent. Early and four-year results from a single-center registry.
Postepy Kardiol Interwencyjnej
December 2020
Department of Interventional Cardiology, Institute of Cardiology, Jagiellonian University, Medical College, John Paul II Hospital, Krakow, Poland.
Introduction: Prevention of peri- and postprocedural complications is still a challenge in carotid artery stenting (CAS).
Aim: To assess immediate and long-term safety and effectiveness of CAS using the Roadsaver double-nitinol-layer-micromesh stent.
Material And Methods: Since 2014, 298 CAS procedures in 287 non-consecutive patients (203 men, mean age 70.
Improved Transcatheter aortic valve implantation for aortic regurgitation using a new-type stent: the first preclinical experience.
J Cardiothorac Surg
September 2020
Department of Cardiology, The 903 Hospital of the Chinese People's Liberation Army, No. 40 JiChang Road, Jianggang District, Hangzhou, 310004, Zhejiang Province, China.
Background: In this study, we sought to evaluate the feasibility of improved transcatheter aortic valve implantation (TAVI) in noncalcified aortic valve by using the novel concept of double-layer ChenValve prosthesis. TAVI was initially considered as an alternative treatment for high-risk patients with aortic stenosis. However, non noncalcified aortic valve disease was considered as a contraindication to TAVI.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!